Various potential risk factors contribute to the formation of PTBE, such as tumor-brain barrier disruption, tumor size, location, tumor margin shape, AQP4/TRPV4 channel co-expression, and vascular endothelial and lymphatic dysfunction (40–42). The gene discussed is AQP4; the disease is neoplasm.